as 04-17-2025 4:00pm EST
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | ARLINGTON |
Market Cap: | N/A | IPO Year: | 2021 |
Target Price: | $27.19 | AVG Volume (30 days): | 949.4K |
Analyst Decision: | Strong Buy | Number of Analysts: | 16 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.11 | EPS Growth: | -42.10 |
52 Week Low/High: | $15.92 - $26.04 | Next Earning Date: | 05-08-2025 |
Revenue: | $1,736,390,000 | Revenue Growth: | 4.75% |
Revenue Growth (this year): | 88.96% | Revenue Growth (next year): | 10.70% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Mountcastle David | PRVA | EVP & Chief Financial Officer | Apr 2 '25 | Sell | $22.38 | 5,630 | $125,999.40 | 179,676 | |
Mehrotra Parth | PRVA | Chief Executive Officer | Mar 12 '25 | Sell | $24.03 | 10,514 | $252,651.42 | 469,381 | |
Mountcastle David | PRVA | EVP & Chief Financial Officer | Mar 10 '25 | Sell | $24.21 | 5,851 | $141,658.23 | 179,676 | |
Mehrotra Parth | PRVA | Chief Executive Officer | Mar 10 '25 | Sell | $24.21 | 18,934 | $458,409.92 | 469,381 | |
Fargis Edward C | PRVA | EVP & General Counsel | Mar 10 '25 | Sell | $24.21 | 4,967 | $120,255.81 | 95,492 | |
Mountcastle David | PRVA | EVP & Chief Financial Officer | Feb 14 '25 | Sell | $25.15 | 100,000 | $2,515,000.00 | 179,676 |
PRVA Breaking Stock News: Dive into PRVA Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
Argus Research
2 days ago
MT Newswires
8 days ago
MT Newswires
9 days ago
StockStory
9 days ago
GlobeNewswire
9 days ago
Argus Research
9 days ago
GlobeNewswire
10 days ago
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.